Aristotle University Of Thessaloniki (AUTH)
Ο ρόλος της βιταμίνης D στο μεταβολισμό της γλυκόζης και των οστών σε ηλικιωμένους ασθενείς με προδιαβήτη
Abstract
dc:descriptionBackground: Data on the efficacy of vitamin Din improving the glycemic status of elderly people with prediabetes are scarce. Additionally, there is a comparative lack of data on bone health in prediabetes. A small number of data concerning the bidirectional relationship between impaired glucose metabolism and depression are available. Through this open-label, randomized-controlled trial we investigated the effect of vitamin D supplementation on glycemic markers and bone metabolism markers of Greek people with prediabetes aged above 60 years, over a period of 12 months. Secondary outcomes include the effect of vitamin D supplementation on anxiety and depression status of elderly people with prediabetes.Research design and methods: Participants were randomly divided into two groups, the intervention and the control group. They were randomly assigned by computer code to receive a weekly dose of vitamin D3 of 25,000 IU in the form of oral solution (intervention group; n = 45) or nothing (control group; n = 45). Anthropometric and glycemic markers were assessed at baseline and 3, 6, and 12 months later and osteoporosis markers were assessed at baseline and 12months.In addition, data from 14 subjects with prediabetes and normal vitamin D levels who constituted the control group for bone metabolism outcomes (bone metabolism control group) were analysed. The State-Trait Anxiety Inventory subscales (STAI-T and STAI-S) and the Patient Health Questionnaire-9 (PHQ-9) were used to evaluate anxiety and depression levels at baseline, 6 and 12 months respectively.Results: Supplemented participants demonstrated significant increase in 25(OH)D concentrations at 6 (26.56 ± 8.64 ng/ml) and 12 months (28.71 ± 9.03 ng/ml) compared to baseline (19.98 ± 6.73 ng/ml, p<0.001 for both comparisons). The mean age of the supplemented participants and the control group was 73.10 ± 7.16 and 74.03 ± 7.64 years, respectively. As far as the intervention group is concerned, fasting glucose was decreased at 6 months compared to baseline (96.12 ± 5.51 vs 103.40 ± 12.05 mg/dl, p < 0.01) and glycated haemoglobin was significantly lower at 6 and 12 months compared to baseline (5.82 ± 0.21% vs 5.87 ± 0.21%, p = 0.004 and 5.80 ± 0.23% vs 5.87 ± 0.21%, p < 0.001, respectively). Furthermore, in prediabetic patients who did not receive vitamin D, our findings showed a trend towards deterioration of bone density, as well as a higher prevalence of osteopenia. The reported deterioration was observed in both the femoral neck and lumbar spine. After 12 months of 25OHD supplementation, the hip fracture risk was found to be reduced. There was no similar finding for major osteoporotic fracture when calculating it with the addition of the BMD parameter, except when it was accounted for with the TBS parameter. None of DEXA markers could be correlated with the glycemic index. The mean STAI-T scores were lower in the supplemented individuals compared to control group at 6 (38.02 ± 9.03 vs 43.91 ± 7.18, p=0.003) and 12 months (32.35 ± 7.77 vs 44.97 ± 7.78, p<0.001). The same pattern was evident for STAI-S scores at 6 (37.11 ± 7.88 vs 43.20 ± 9.33, p=0.003) and 12 months (32.59 ± 6.45 vs 44.60 ± 9.53, p<0.001). Supplemented participants demonstrated lower mean PHQ-9 scores compared to the participants in the control group at 6 (15.69 ± 6.15 vs 19.77 ± 8.96, p=0.021) and 12 months (13.52 ± 5.01 vs 20.20 ± 8.67, p<0.001). Conclusions: Vitamin D could be complementary to a lifestyle change strategy for the management of prediabetes in the elderly. Vitamin D supplementation could have a beneficial effect in the 10th-year probability of fracture, which tended to be lower compared to people who did not take supplementation. A weekly vitamin D supplementation scheme could be effective in alleviating anxiety and depression symptoms.Clinical trial registration: ISRCTN51643592
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zaromytidou, Evangelia
- Ζαρομυτίδου, Ευαγγελία
Subjects
dc:subject × 16- Βιταμίνη D
- Προδιαβήτης
- Αγχώδεις διαταραχές
- Κατάθλιψη
- Οστεοπόρωση
- Vitamin D
- Prediabetes
- Anxiety disorders
- Depression
- Osteoporosis
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ενδοκρινολογία, Διαβήτης και Μεταβολισμός
- Clinical Medicine
- Medical and Health Sciences
- Endocrinology, Diabetes and Metabolism
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/53251